Opioid receptor modulator dosage formulations | Patent Publication Number 20210205269

US 20210205269 A1
Patent NumberUS 11160792 B2
Application Number17211274
Filled DateMar 24, 2021
Priority DateMar 14, 2013
Publication DateJul 8, 2021
Original AssigneeAbbvie Inc.
Current AssigneeAllergan Holdings France S.a.s.
Inventor/ApplicantsJens Jozef Ceulemans
Philip Ema H. Heyns
Philip Erna H. Heyns
Eugeen Maria Jozef Jans
Tim Costello
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.